Topical 2% Simvastatin for Xanthelasma Palpebrarum

Clinical trial NCT07662785 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07662785
Sponsor: Klira Skin
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Xanthelasma Palpebrarum

Start date: 2026-08-01
Primary completion: 2027-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.